Condition
Organ Dysfunction Syndrome Sepsis
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 3 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04316884Completed
Mechanisms for Organ Dysfunction in Covid-19
NCT04580888Not ApplicableCompleted
Emergency Echocardiography in Sepsis
NCT04508946Phase 3Completed
Triple Therapy in Septic Shock Patients
NCT03925857Phase 1CompletedPrimary
Prevention of Sepsis-related Organ Dysfunction With Allocetra-OTS
Showing all 4 trials